Sahara Neupane

Sahara Neupane practices at MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health.

Sahara Neupane's NPI, 1912389073, was assigned on June 25, 2015. Sahara Neupane holds Pennsylvania license MD465621.

Sahara Neupane's primary practice is MedStar Good Samaritan Hospital, at 5601 Loch Raven Boulevard, Baltimore, MD 21239 in Baltimore City. The practice phone is (443) 444-3902.

Sahara Neupane's primary practice is MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health. Sahara Neupane is also affiliated with MedStar Union Memorial Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Sahara Neupane to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sahara Neupane practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Sahara Neupane's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Sahara Neupane is licensed in Pennsylvania.

CMS data shows 1,024 Medicare services from Sahara Neupane across 4 procedure codes in 2024, for 288 Medicare patients. Medicare paid $108,528 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 288 Medicare patients who saw Sahara Neupane in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sahara Neupane's median patient age at 65, with 60% women.

In 2024, Sahara Neupane wrote 168 Medicare Part D claims for 97 patients. 90% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $95 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Sahara Neupane for performance year 2024, reported as part of a group. Sahara Neupane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Sahara Neupane from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Insulet Corporation paid the most, $26.